rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2001-8-27
|
pubmed:abstractText |
Hyperlipidaemia and endothelial dysfunction are common features in cyclosporin A (CsA)-treated renal transplant recipients. Endothelial dysfunction may contribute to the risk of premature atherosclerosis and cardiovascular death in these patients. A beneficial effect of statin therapy beyond cholesterol lowering may be an improvement of endothelial function. The present study was designed to assess the effect of atorvastatin on serum lipids and endothelial function in CsA treated renal transplant recipients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0931-0509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1920-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11522880-Adult,
pubmed-meshheading:11522880-Aged,
pubmed-meshheading:11522880-Endothelium, Vascular,
pubmed-meshheading:11522880-Female,
pubmed-meshheading:11522880-Forearm,
pubmed-meshheading:11522880-Heptanoic Acids,
pubmed-meshheading:11522880-Humans,
pubmed-meshheading:11522880-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:11522880-Kidney Transplantation,
pubmed-meshheading:11522880-Lipids,
pubmed-meshheading:11522880-Male,
pubmed-meshheading:11522880-Microcirculation,
pubmed-meshheading:11522880-Middle Aged,
pubmed-meshheading:11522880-Nitric Oxide,
pubmed-meshheading:11522880-Pilot Projects,
pubmed-meshheading:11522880-Pyrroles,
pubmed-meshheading:11522880-Skin
|
pubmed:year |
2001
|
pubmed:articleTitle |
Atorvastatin improves endothelial function in renal-transplant recipients.
|
pubmed:affiliation |
Laboratory for Renal Physiology, Section of Nephrology, Medical Department, The National Hospital, N-0027 Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|